Home - IPOPI

Improving PID patients’ lives. Worldwide.

Home
About IPOPI
Our Work
- IPOPI strategic plan
- Donate to IPOPI
PIDs
- What are Primary Immunodeficiencies?
- PIDs FAQs
NMOs
- IPOPI NMO Toolkit
- NMO Documents
•
Menu

Publications
PID Life Index
Media
e-News
IPOPI TV

IVIG-Therapy-1024×597 — NEWS
IPOPI statement on access to IG therapies
Read position statement
13th May 2026/by IPOPI

Claude Griscelli _ _Je n’avais aucune raison de modifier ce rapport_ — NEWS
In Memoriam – Prof Claude Griscelli
Read the tribute
7th May 2026/by IPOPI

NEWS
IPOPI welcomes EU authorisation of XOLREMDI TM
Read article
7th May 2026/by IPOPI

PID Forum — NEWS
IPOPI PID Forum addresses ageing with PIDs
Read article
6th May 2026/by IPOPI

Some members of the IPOPI Board and Staff — NEWS
IPOPI at the International Plasma Protein Congress in Milan
Read article
30th April 2026/by IPOPI

Group Picture_Asian PID Patients and Doctors Meeting — NEWS
Regional Asian PID Patients and Doctors‘ Meeting
Read article
12th March 2026/by IPOPI

NEWS
Mini-Doc: The Life Journey with Primary Immunodeficiencies
Read article
16th February 2026/by IPOPI

14-16 October 2026

Global PID Patients' Meeting

Maastricht, Netherlands

IPOPI

Related Events

Know more about other events

interactive
PID Life Index

This is an interactive tool that measures the status of the PID healthcare environment across the globe.

Home
About IPOPI
Our Work
- IPOPI strategic plan
- Donate to IPOPI
PIDs
- What are Primary Immunodeficiencies?
- PIDs FAQs
NMOs
- IPOPI NMO Toolkit
- NMO Documents

Publications
PID Life Index
Media
e-News
IPOPI TV

Privacy Policy and Cookies

Privacy Policy
Cookies Policy
Change cookie settings

Contact us

Belgium
Avenue Louise/Louizalaan 65, Bte 11
BE-1050 Brussels, Belgium
IPOPI aisbl is an international non-profit association registered in Belgium
Numéro d’entreprise
BE 0761.784.055

Email: info@ipopi.org

Tel: +32 2 790 73 66 (Belgium)

Social Media

Website sponsors

Copyright © 2026 IPOPI. All Rights Reserved.

Scroll to top